Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats

Yan Liu, Takuya Tsuchihashi, Shuntaro Kagiyama, Kiyoshi Matsumura, Isao Abe, Masatoshi Fujishima

研究成果: ジャーナルへの寄稿記事

25 引用 (Scopus)

抄録

Objective. To study the possible central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase. Methods. We evaluated neurohormonal and renal responses of Wistar rats to chronic oral administration of 20 and 100 mg/kg per day N(G)-nitro-L-arginine methyl ester (L-NAME). Effects of intracerebroventricular and intravenous injections of NO donors (NOC-18 and FK-409) and an angiotensin II type 1 receptor antagonist CV-11974, and intravenous injection of α-adrenergic receptor antagonist phentolamine after chronic treatment with 100 mg/kg per day L-NAME were also studied. Results. The chronic treatment with L-NAME induced a sustained dose-dependent hypertension with a decrease in heart rate. Urinary levels of norepinephrine and epinephrine decreased with no changes in plasma catecholamine levels, renin activity, and vasopressin level. Serum nitrate/nitrite levels in the rats treated with the high dose of L-NAME decreased. The intracerebroventricular and intravenous injections of the NO donors reduced arterial pressure in L-NAME-treated rats to a significantly greater extent than they did that in control rats. The intravenous but not intracerebroventricular injection of CV-11974 produced a sustained decrease in arterial pressure of L-NAME-treated rats. The depressor responses to intravenous injection of phentolamine of L-NAME-treated and control rats were similar. Conclusions. Results indicate that L-NAME-induced hypertension is associated with a deficiency of nitric oxide, both peripherally and centrally. Circulating angiotensin II could contribute to the maintenance of hypertension via angiotensin II type 1 receptor while the sympathetic nervous system seems to be suppressed.

元の言語英語
ページ(範囲)1165-1173
ページ数9
ジャーナルJournal of hypertension
16
発行部数8
出版物ステータス出版済み - 7 30 1998

Fingerprint

NG-Nitroarginine Methyl Ester
Nitric Oxide Synthase
Hypertension
Intravenous Injections
Phentolamine
Arterial Pressure
Angiotensin II Type 1 Receptor Blockers
Angiotensin Type 1 Receptor
Adrenergic Antagonists
Sympathetic Nervous System
Nitrites
Vasopressins
Renin
Angiotensin II
Nitrates
Epinephrine
Catecholamines
Oral Administration
Wistar Rats
Norepinephrine

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

これを引用

Liu, Y., Tsuchihashi, T., Kagiyama, S., Matsumura, K., Abe, I., & Fujishima, M. (1998). Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. Journal of hypertension, 16(8), 1165-1173.

Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. / Liu, Yan; Tsuchihashi, Takuya; Kagiyama, Shuntaro; Matsumura, Kiyoshi; Abe, Isao; Fujishima, Masatoshi.

:: Journal of hypertension, 巻 16, 番号 8, 30.07.1998, p. 1165-1173.

研究成果: ジャーナルへの寄稿記事

Liu, Y, Tsuchihashi, T, Kagiyama, S, Matsumura, K, Abe, I & Fujishima, M 1998, 'Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats', Journal of hypertension, 巻. 16, 番号 8, pp. 1165-1173.
Liu Y, Tsuchihashi T, Kagiyama S, Matsumura K, Abe I, Fujishima M. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. Journal of hypertension. 1998 7 30;16(8):1165-1173.
Liu, Yan ; Tsuchihashi, Takuya ; Kagiyama, Shuntaro ; Matsumura, Kiyoshi ; Abe, Isao ; Fujishima, Masatoshi. / Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. :: Journal of hypertension. 1998 ; 巻 16, 番号 8. pp. 1165-1173.
@article{fa433266812b4e3e8df751d5bbe9567c,
title = "Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats",
abstract = "Objective. To study the possible central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase. Methods. We evaluated neurohormonal and renal responses of Wistar rats to chronic oral administration of 20 and 100 mg/kg per day N(G)-nitro-L-arginine methyl ester (L-NAME). Effects of intracerebroventricular and intravenous injections of NO donors (NOC-18 and FK-409) and an angiotensin II type 1 receptor antagonist CV-11974, and intravenous injection of α-adrenergic receptor antagonist phentolamine after chronic treatment with 100 mg/kg per day L-NAME were also studied. Results. The chronic treatment with L-NAME induced a sustained dose-dependent hypertension with a decrease in heart rate. Urinary levels of norepinephrine and epinephrine decreased with no changes in plasma catecholamine levels, renin activity, and vasopressin level. Serum nitrate/nitrite levels in the rats treated with the high dose of L-NAME decreased. The intracerebroventricular and intravenous injections of the NO donors reduced arterial pressure in L-NAME-treated rats to a significantly greater extent than they did that in control rats. The intravenous but not intracerebroventricular injection of CV-11974 produced a sustained decrease in arterial pressure of L-NAME-treated rats. The depressor responses to intravenous injection of phentolamine of L-NAME-treated and control rats were similar. Conclusions. Results indicate that L-NAME-induced hypertension is associated with a deficiency of nitric oxide, both peripherally and centrally. Circulating angiotensin II could contribute to the maintenance of hypertension via angiotensin II type 1 receptor while the sympathetic nervous system seems to be suppressed.",
author = "Yan Liu and Takuya Tsuchihashi and Shuntaro Kagiyama and Kiyoshi Matsumura and Isao Abe and Masatoshi Fujishima",
year = "1998",
month = "7",
day = "30",
language = "English",
volume = "16",
pages = "1165--1173",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats

AU - Liu, Yan

AU - Tsuchihashi, Takuya

AU - Kagiyama, Shuntaro

AU - Matsumura, Kiyoshi

AU - Abe, Isao

AU - Fujishima, Masatoshi

PY - 1998/7/30

Y1 - 1998/7/30

N2 - Objective. To study the possible central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase. Methods. We evaluated neurohormonal and renal responses of Wistar rats to chronic oral administration of 20 and 100 mg/kg per day N(G)-nitro-L-arginine methyl ester (L-NAME). Effects of intracerebroventricular and intravenous injections of NO donors (NOC-18 and FK-409) and an angiotensin II type 1 receptor antagonist CV-11974, and intravenous injection of α-adrenergic receptor antagonist phentolamine after chronic treatment with 100 mg/kg per day L-NAME were also studied. Results. The chronic treatment with L-NAME induced a sustained dose-dependent hypertension with a decrease in heart rate. Urinary levels of norepinephrine and epinephrine decreased with no changes in plasma catecholamine levels, renin activity, and vasopressin level. Serum nitrate/nitrite levels in the rats treated with the high dose of L-NAME decreased. The intracerebroventricular and intravenous injections of the NO donors reduced arterial pressure in L-NAME-treated rats to a significantly greater extent than they did that in control rats. The intravenous but not intracerebroventricular injection of CV-11974 produced a sustained decrease in arterial pressure of L-NAME-treated rats. The depressor responses to intravenous injection of phentolamine of L-NAME-treated and control rats were similar. Conclusions. Results indicate that L-NAME-induced hypertension is associated with a deficiency of nitric oxide, both peripherally and centrally. Circulating angiotensin II could contribute to the maintenance of hypertension via angiotensin II type 1 receptor while the sympathetic nervous system seems to be suppressed.

AB - Objective. To study the possible central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase. Methods. We evaluated neurohormonal and renal responses of Wistar rats to chronic oral administration of 20 and 100 mg/kg per day N(G)-nitro-L-arginine methyl ester (L-NAME). Effects of intracerebroventricular and intravenous injections of NO donors (NOC-18 and FK-409) and an angiotensin II type 1 receptor antagonist CV-11974, and intravenous injection of α-adrenergic receptor antagonist phentolamine after chronic treatment with 100 mg/kg per day L-NAME were also studied. Results. The chronic treatment with L-NAME induced a sustained dose-dependent hypertension with a decrease in heart rate. Urinary levels of norepinephrine and epinephrine decreased with no changes in plasma catecholamine levels, renin activity, and vasopressin level. Serum nitrate/nitrite levels in the rats treated with the high dose of L-NAME decreased. The intracerebroventricular and intravenous injections of the NO donors reduced arterial pressure in L-NAME-treated rats to a significantly greater extent than they did that in control rats. The intravenous but not intracerebroventricular injection of CV-11974 produced a sustained decrease in arterial pressure of L-NAME-treated rats. The depressor responses to intravenous injection of phentolamine of L-NAME-treated and control rats were similar. Conclusions. Results indicate that L-NAME-induced hypertension is associated with a deficiency of nitric oxide, both peripherally and centrally. Circulating angiotensin II could contribute to the maintenance of hypertension via angiotensin II type 1 receptor while the sympathetic nervous system seems to be suppressed.

UR - http://www.scopus.com/inward/record.url?scp=0031874685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031874685&partnerID=8YFLogxK

M3 - Article

C2 - 9794721

AN - SCOPUS:0031874685

VL - 16

SP - 1165

EP - 1173

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 8

ER -